Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study
<p>Abstract</p> <p>Background</p> <p>A consensus on the most reliable staging system for hepatocellular carcinoma (HCC) is still lacking but the most used is a revised Barcelona Clinic Liver Cancer (BCLC) system, adopted by the American Association for the Study of Live...
Main Authors: | Zoli Marco, Rapaccini Gianludovico, Benvegnu Luisa, Del Poggio Paolo, Di Nolfo Maria, Giacomin Anna, Baldan Anna, Sergio Adriana, Farinati Fabio, Borzio Franco, Giannini Edoardo G, Caturelli Eugenio, Trevisani Franco |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/33 |
Similar Items
-
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
by: Fabio Farinati, et al.
Published: (2016-04-01) -
How much do we really know about the lives of early Christ followers?
by: Carolyn Osiek
Published: (2011-04-01) -
How Much Does Strategy Matter, Really?
by: Peter G. Klein, et al.
Published: (2021-09-01) -
Thank you very much!
by: David Normando -
The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidence
by: Franco Trevisani, et al.
Published: (2022-01-01)